Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. (Q54027653)
Jump to navigation
Jump to search
scientific article published in July 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. |
scientific article published in July 1994 |
Statements
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. (English)
G Catimel
J Verweij
V Mattijssen
A Hanauske
M Piccart
J Wanders
H Franklin
N Le Bail
M Clavel
S B Kaye
1 July 1994
5
6
533-537